ArticleFrontiers in oncology2019

The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.

Kaifang Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.